A new analysis of lung epithelial cells from COVID-19 patients reveals how the protective complement branch of the immune system, which usually plays roles in both innate and adaptive immunity, can convert to a harmful system during COVID-19. Blocking excessive complement activity in lung epithelial cells with a combination of existing chemotherapy and antiviral medications - ruxolitinib and remdesivir, respectively - helped normalize the production of complement proteins by infected lung epithelial cells in human cell culture experiments, the researchers found.
Thus, the drug duo could serve as a promising strategy to treat damaging inflammation during severe COVID-19, the authors say.
Overactivation of complement proteins can contribute to diseases such as acute respiratory distress syndrome, and increasing evidence suggests that excessive complement responses also correlate with disease severity in patients with severe COVID-19. However, it remains unclear what rewires this normally protective system into a dangerous one during severe COVID-19.
To dig into this question, the authors analyzed bulk and single cell RNA-sequencing data from blood and lung tissues of patients with COVID-19 and compared them with those from healthy controls. In COVID-19 patients, the complement system was one of the most highly induced pathways in lung epithelial cells infected by SARS-CoV-2, as indicated by the high expression of genes that control expression and activation of complement protein C3.
Further analyses showed that the IFN-JAK1/2-STAT1 inflammatory pathway and NF-κB transcription factor were highly involved in the transcription of complement genes in infected lung epithelial cells. Blocking these pathways using the cancer chemotherapy drug ruxolitinib helped normalize expression of complement and IFN-controlling genes in human lung epithelial cell lines.
Combining ruxolitinib with the antiviral drug remdesivir additionally blocked NF-κB activity, inhibiting overproduction of C3a by infected cells and further normalizing the transcription and production of complement protein fragments.
This heightened understanding of the complement system's contribution to COVID-19 could drive the discovery of much-needed treatments, the authors say.
https://immunology.sciencemag.org/content/6/58/eabg0833
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fsars-cov-2-drives-jak1&filter=22
Role of complement system in COVID-19
- 1,422 views
- Added
Edited
Latest News
Multiomics identifies ALS s…
By newseditor
Posted 28 Jun
Reducing age-related inflam…
By newseditor
Posted 28 Jun
Alzheimer's disease symptom…
By newseditor
Posted 27 Jun
Gene-regulatory networks in…
By newseditor
Posted 27 Jun
How apoE influences Aβ aggr…
By newseditor
Posted 26 Jun
Other Top Stories
Protein essential for healthy gut cell development identified!
Read more
Reprogramming of liver cells to pancreas progenitor cells based on…
Read more
The intestine has a reservoir of stem cells that are resistant to c…
Read more
Unproven stem cell 'therapy' blinds three patients at Florida clinic
Read more
Neural crest cells from adult skin cells without genetic modification!
Read more
Protocols
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
Publications
TMC7 functions as a suppres…
By newseditor
Posted 29 Jun
Multiomic ALS signatures hi…
By newseditor
Posted 28 Jun
What Is Thyroid Cancer?
By newseditor
Posted 28 Jun
Neurobiological basis of st…
By newseditor
Posted 28 Jun
Immunometabolism in atheros…
By newseditor
Posted 27 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar